Papers: 28 Mar 2014 - 4 Apr 2014
Sera from remitting and secondary progressive multiple sclerosis patients disrupt the blood-brain barrier.
Labour-associated increase in C-reactive protein concentration is not predictive of postpartum relapse activity among mothers with multiple sclerosis.
Tumor necrosis factor beta (TNF-β) NcoI polymorphism is associated with multiple sclerosis in Caucasian patients from Southern Brazil independently from HLA-DRB1.
Thrombotic thrombocytopenic purpura-haemolytic uremic syndrome in relapsing-remitting multiple sclerosis patients on high-dose interferon beta.
Successful treatment of fingolimod-associated macular edema with intravitreal triamcinolone with continued fingolimod use.
Interest in providing multiple sclerosis care and subspecializing in multiple sclerosis among neurology residents.
Nurses' perspective on approaches to limit flu-like symptoms during interferon therapy for multiple sclerosis.
Comparing two conditions of administering the six-minute walk test in people with multiple sclerosis.
The TRUST (EvaluaTion of Bladder Function in Relapsing-Remitting MUltiple Sclerosis Patients Treated with Natalizumab) Observational Study.
Satellite glial cells in dorsal root ganglia are activated in experimental autoimmune encephalomyelitis.
Brain networks disconnection in early multiple sclerosis cognitive deficits: An anatomofunctional study.
Impact of Clear, Loud and Slow Speech on Scaled Intelligibility and Speech Severity in Parkinson's Disease and Multiple Sclerosis.
Cerebrospinal fluid immunoglobulin kappa light chain in clinically isolated syndrome and multiple sclerosis.
Reliability and Validity of PROMIS Cognitive Abilities and Cognitive Concerns Scales Among People with Multiple Sclerosis.
Cognitive motor interference during walking in multiple sclerosis using an alternate letter alphabet task.
Monocular and binocular low-contrast visual acuity and optical coherence tomography in pediatric multiple sclerosis.
Altered Expression of Oligodendrocyte and Neuronal Marker Genes Predicts the Clinical Onset of Autoimmune Encephalomyelitis and Indicates the Effectiveness of Multiple Sclerosis-Directed Therapeutics.
Genome-wide analysis of wild-type Epstein-Barr virus genomes derived from healthy individuals of the 1000 Genomes Project.
HLA-DRα1 Constructs Block CD74 Expression and MIF Effects in Experimental Autoimmune Encephalomyelitis.
Assessment of postural stabilization in three task oriented movements in people with multiple sclerosis.
Sphingosine-1-phosphate receptors control B-cell migration through signaling components associated with primary immunodeficiencies, chronic lymphocytic leukemia, and multiple sclerosis.
Stressful life-events in childhood and risk of multiple sclerosis: a Danish nationwide cohort study.
Longitudinal evaluation of cognitive functioning in pediatric multiple sclerosis: report from the US Pediatric Multiple Sclerosis Network.
No evidence for an association of osteopontin plasma levels with disease activity in multiple sclerosis.
The onset location of neuromyelitis optica spectrum disorder predicts the location of subsequent relapses.
Antiinflammatory activity of glucomoringin isothiocyanate in a mouse model of experimental autoimmune encephalomyelitis.
Therapeutic Plasma Exchange in Glucocorticosteroid-Unresponsive Patients With Clinically Isolated Syndrome.
Changes in B and T-cell subsets and NMO-IgG levels after immunoglobulins and rituximab treatment for an acute attack of neuromyelitis optica.
Pathologic and imaging correlates of cognitive deficits in multiple sclerosis: changing the paradigm of diagnosis and prognosis.
Delta-9-tetrahydrocannabinol/cannabidiol (sativex(®)): a review of its use in patients with moderate to severe spasticity due to multiple sclerosis.
Differentiating white matter lesions in multiple sclerosis and migraine using monoexponential and biexponential diffusion measurements.
Adoptive transfer of cytokine-induced immunomodulatory adult microglia attenuates experimental autoimmune encephalomyelitis in DBA/1 mice.
The selective anti-IL17A monoclonal antibody secukinumab (AIN457) attenuates IL17A-induced levels of IL6 in human astrocytes.
Parent-of-Origin Effects Implicate Epigenetic Regulation of Experimental Autoimmune Encephalomyelitis and Identify Imprinted Dlk1 as a Novel Risk Gene.
Understanding balance differences in individuals with multiple sclerosis with mild disability: an investigation of differences in sensory feedback on postural control during a Romberg task.
Evaluation of contrast sensitivity measurements after retrobulbar optic neuritis in Multiple Sclerosis.
N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities.
Systematic framework to evaluate the status of physical activity research for persons with multiple sclerosis.